283 related articles for article (PubMed ID: 32287314)
21. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
[TBL] [Abstract][Full Text] [Related]
22. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
23. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies.
Boyd M; Thodberg M; Vitezic M; Bornholdt J; Vitting-Seerup K; Chen Y; Coskun M; Li Y; Lo BZS; Klausen P; Jan Schweiger P; Pedersen AG; Rapin N; Skovgaard K; Dahlgaard K; Andersson R; Terkelsen TB; Lilje B; Troelsen JT; Petersen AM; Jensen KB; Gögenur I; Thielsen P; Seidelin JB; Nielsen OH; Bjerrum JT; Sandelin A
Nat Commun; 2018 Apr; 9(1):1661. PubMed ID: 29695774
[TBL] [Abstract][Full Text] [Related]
25. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease.
Abreu-Delgado Y; Isidro RA; Torres EA; González A; Cruz ML; Isidro AA; González-Keelan CI; Medero P; Appleyard CB
World J Gastroenterol; 2016 Apr; 22(13):3581-91. PubMed ID: 27053850
[TBL] [Abstract][Full Text] [Related]
26. Serum Serotonin Differentiates Between Disease Activity States in Crohn's Patients.
Manzella CR; Jayawardena D; Pagani W; Li Y; Alrefai WA; Bauer J; Jung B; Weber CR; Gill RK
Inflamm Bowel Dis; 2020 Sep; 26(10):1607-1618. PubMed ID: 32844174
[TBL] [Abstract][Full Text] [Related]
27. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and Classification of Inflammatory Bowel Disease Strictures.
Levy AN
Gastrointest Endosc Clin N Am; 2022 Oct; 32(4):615-629. PubMed ID: 36202506
[TBL] [Abstract][Full Text] [Related]
29. ER stress activation in the intestinal mucosa but not in mesenteric adipose tissue is associated with inflammation in Crohn's disease patients.
Coope A; Pascoal LB; Botezelli JD; da Silva FAR; Ayrizono MLS; Rodrigues BL; Milanski M; Carvalho RB; Fagundes JJ; Velloso LA; Leal RF
PLoS One; 2019; 14(9):e0223105. PubMed ID: 31557250
[TBL] [Abstract][Full Text] [Related]
30. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
[TBL] [Abstract][Full Text] [Related]
32. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
33. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease.
Rieder F; Bettenworth D; Ma C; Parker CE; Williamson LA; Nelson SA; van Assche G; Di Sabatino A; Bouhnik Y; Stidham RW; Dignass A; Rogler G; Taylor SA; Stoker J; Rimola J; Baker ME; Fletcher JG; Panes J; Sandborn WJ; Feagan BG; Jairath V
Aliment Pharmacol Ther; 2018 Aug; 48(3):347-357. PubMed ID: 29920726
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Small Bowel Lesions Using Capsule Endoscopy in Ulcerative Colitis and Crohn's Disease: A Single-Center Retrospective Analysis.
Ninomiya K; Hisabe T; Okado Y; Takada Y; Yamaoka R; Sato Y; Kishi M; Takatsu N; Matsui T; Ueki T; Yao K; Hirai F
Digestion; 2018; 98(2):119-126. PubMed ID: 29698945
[TBL] [Abstract][Full Text] [Related]
35. Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease.
Ichimiya T; Kazama T; Ishigami K; Yokoyama Y; Hayashi Y; Takahashi S; Itoi T; Nakase H
PLoS One; 2023; 18(6):e0286415. PubMed ID: 37352151
[TBL] [Abstract][Full Text] [Related]
36. Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients.
Gupta N; Bostrom AG; Kirschner BS; Ferry GD; Gold BD; Cohen SA; Winter HS; Baldassano RN; Abramson O; Smith T; Heyman MB
Inflamm Bowel Dis; 2010 Apr; 16(4):638-44. PubMed ID: 19760783
[TBL] [Abstract][Full Text] [Related]
37. Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?
Gravina AG; Panarese I; Trotta MC; D'Amico M; Pellegrino R; Ferraraccio F; Galdiero M; Alfano R; Grieco P; Federico A
World J Gastroenterol; 2024 Mar; 30(9):1132-1142. PubMed ID: 38577176
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.
Teng X; Yang Y; Liu L; Yang L; Wu J; Sun M; Xu L
Pediatr Res; 2020 Nov; 88(5):792-795. PubMed ID: 32120375
[TBL] [Abstract][Full Text] [Related]
40. Distinct Alterations in the Composition of Mucosal Innate Lymphoid Cells in Newly Diagnosed and Established Crohn's Disease and Ulcerative Colitis.
Forkel M; van Tol S; Höög C; Michaëlsson J; Almer S; Mjösberg J
J Crohns Colitis; 2019 Jan; 13(1):67-78. PubMed ID: 30496425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
